Affiliation:
1. Pharmaceutical Sciences, Baxalta Innovations GmbH, Now Part of the Takeda Group of Companies, 1221 Vienna, Austria
2. Global Pathogen Safety, Takeda Manufacturing Austria AG, 1221 Vienna, Austria
Abstract
For decades, the ability of detergents to solubilize biological membranes has been utilized in biotechnological manufacturing to disrupt the lipid envelope of potentially contaminating viruses and thus enhance the safety margins of plasma- and cell-derived drugs. This ability has been linked to detergent micelles, which are formed if the concentration of detergent molecules exceeds the critical micelle concentration (CMC). Traditionally, the CMC of detergents is determined in deionized water (ddH2O), i.e., a situation considerably different from the actual situation of biotechnological manufacturing. This study compared, for five distinct detergents, the CMC in ddH2O side-by-side with two biopharmaceutical process intermediates relevant to plasma-derived (Immunoglobulin) and cell-derived (monoclonal antibody) products, respectively. Depending on the matrix, the CMC of detergents changed by a factor of up to ~4-fold. Further, the CMC in biotechnological matrices did not correlate with antiviral potency, as Triton X-100 (TX-100) and similar detergents had comparatively higher CMCs than polysorbate-based detergents, which are known to be less potent in terms of virus inactivation. Finally, it was demonstrated that TX-100 and similar detergents also have virus-inactivating properties if applied below the CMC. Thus, the presence of detergent micelles might not be an absolute prerequisite for the disruption of virus envelopes.
Funder
Takeda Manufacturing Austria AG
Subject
Inorganic Chemistry,Organic Chemistry,Physical and Theoretical Chemistry,Computer Science Applications,Spectroscopy,Molecular Biology,General Medicine,Catalysis
Reference22 articles.
1. HIV transmission to patients with hemophilia by heat-treated, donor-screened factor concentrate;Remis;CMAJ Can. Med. Assoc. J.,1990
2. Non-A non-B hepatitis after transfusion of factor VIII in infrequently treated patients;Fletcher;Br. Med. J. (Clin. Res. Ed.),1983
3. Inactivation of viruses in labile blood derivatives. I. Disruption of lipid-enveloped viruses by tri(n-butyl)phosphate detergent combinations;Horowitz;Transfusion,1985
4. Robustness of solvent/detergent treatment of plasma derivatives: A data collection from Plasma Protein Therapeutics Association member companies;Dichtelmueller;Transfusion,2009
5. ECHA (2022, March 03). Member State Committee Support Document for Identification of 4-(1,1,3,3,-Tetramethybutyl)Phenol, 4-Tert-Octylphenol as a Substance of very High Concern Because Its Endocrine Disrupting Properties Cause Probable Serious Effects to the Environment Which Gives Rise to an Equivalent Level of Concern. Available online: https://echa.europa.eu/documents/10162/4c6cccfd-d366-4a00-87e5-65aa77181fb6.
Cited by
4 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献